What question did this study set out to answer?

This research aims to evaluate the effectiveness and safety of cardiac glycosides in heart failure treatment.

April 1, 1984British Journal of Clinical PharmacologyOpen Access

The role of digitalis in the future.

View Full Paper

Ask AI

Bookmark

Why the study?

What is the role of digitalis in the treatment of heart failure?

Key Points

This research aims to evaluate the effectiveness and safety of cardiac glycosides in heart failure treatment.
Reviewed the effects of cardiac glycosides on heart function over several months.
Assessed patient responses to long-term treatment with digoxin and other glycosides.
Analyzed the implications of new treatment options like diuretics and vasodilators on the use of glycosides.
Long-term positive inotropic effect of cardiac glycosides is confirmed but benefits vary.
Only a small subset of patients shows symptom relief, raising efficacy concerns.
Mortality effects of digoxin are not established, making its use in mild heart failure questionable.

Structured PICO

What is the role of digitalis in the treatment of heart failure?

Population

Patients with normal and failing heart (mild to severe chronic heart failure)

Intervention

Cardiac glycosides (digitalis/digoxin)

The routine use of digitalis in heart failure is questionable given uncertain long-term benefits, lack of mortality benefit, and the availability of safer, more effective alternative therapies.

Implication

Questions routine digitalis use in HF; leaves open need for updated RCTs versus contemporary therapies.

Abstract

Cardiac glycosides exert an acute positive inotropic effect on the normal and failing heart. Recent evidence establishes that the positive inotropic effect is maintained over several months in many patients. The effectiveness of long-term treatment with cardiac glycosides in relieving symptoms is less certain; only a small subset of patients benefits. An effect on mortality is not established. The use of digoxin in the treatment of mild heart failure is questionable since the drug has serious side-effects and the efficacy in patients already taking diuretics has not been established. The use of glycosides in the treatment of severe chronic heart failure is being challenged because of the availability of powerful diuretics, new vasodilators and alternative positive inotropes.